Seeing Is Believing

Currently out of the existing stock ratings of Suraj Kalia, 200 are a BUY (78.43%), 34 are a HOLD (13.33%), 21 are a SELL (8.24%).
Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 54.25% that have a potential upside of 35.5% achieved within 229 days.
Suraj Kalia’s has documented 483 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Industrials, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 21-Sep-2026.
Analyst best performing recommendations are on ATRC (ATRICURE).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Jun-2021
$388
$6.98 (1.83%)
$355
3 years 11 months ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Sell Since 15-Jul-2022
$380
$-1.02 (-0.27%)
$235
3 years 11 months ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Buy Since 22-Feb-2018
$380
$-1.02 (-0.27%)
$350
3 years 11 months 1 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy Since 30-Jun-2021
$300
3 years 11 months 19 days ago
(13-Oct-2022)
1/3 (33.33%)
$57.23 (23.57%)
20
$330
$-47.78 (-12.65%)
4 years 5 months 26 days ago
(06-Apr-2022)
1/1 (100%)
$16.24 (5.18%)
209
Which stock is Suraj Kalia most bullish on?
Which stock is Suraj Kalia most reserved on?
What Year was the first public recommendation made by Suraj Kalia?